Advances in the development of covalent small molecule inhibitors of monoacylglycerol lipase / 生物工程学报
Chinese Journal of Biotechnology
;
(12): 4397-4412, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-1008032
ABSTRACT
Monoacylglycerol lipase (MGL) is a serine hydrolase that plays a major role in the degradation of endogenous cannabinoid 2-arachidonoylglycerol. The role of MGL in some cancer cells has been confirmed, where inhibition of the MGL activity shows inhibition on cell proliferation. This makes MGL a promising drug target for the treatment of cancer. Recently, the development of covalent inhibitors of MGL has developed rapidly. These drugs have strong covalent binding ability, high affinity, long duration, low dose and low risk of drug resistance, so they have received increasing attention. This article introduces the structure and function of MGL, the characteristics, mechanisms and progress of covalent MGL inhibitors, providing reference for the development of novel covalent small molecule inhibitors of MGL.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Endocannabinoids
/
Monoacylglycerol Lipases
Language:
Chinese
Journal:
Chinese Journal of Biotechnology
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS